Vital Farms Inc
For the period ended Dec 29, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
SIGNA TURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| VITAL FARMS, INC. | ||
| Date: February 27, 2025 | By: | /s/ Russell Diez-Canseco |
|---|---|---|
| Name: | Russell Diez-Canseco | |
| Title: | President and Chief Executive Officer |
POWER OF ATTORNEY
Each person whose individual signature appears below hereby authorizes and appoints Russell Diez-Canseco and Thilo Wrede, and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons, on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | Title | Date |
|---|---|---|
| /s/ Russell Diez-Canseco | President, Chief Executive Officer and Director | February 27, 2025 |
| Russell Diez-Canseco | (Principal Executive Officer) | |
| /s/ Thilo Wrede | Chief Financial Officer | February 27, 2025 |
| Thilo Wrede | (Principal Financial and Accounting Officer) | |
| /s/ Matthew O’Hayer | Executive Chairperson and Director | February 27, 2025 |
| Matthew O’Hayer | ||
| /s/ Kofi Amoo-Gottfried | Director | February 27, 2025 |
| Kofi Amoo-Gottfried | ||
| /s/ Glenda Flanagan | Director | February 27, 2025 |
| Glenda Flanagan | ||
| /s/ Kelly Kennedy | Director | February 27, 2025 |
| Kelly Kennedy | ||
| /s/ Karl Khoury | Director | February 27, 2025 |
| Karl Khoury | ||
| /s/ Denny Marie Post | Director | February 27, 2025 |
| Denny Marie Post | ||
| /s/ Gisel Ruiz | Director | February 27, 2025 |
| Gisel Ruiz | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.